According to three government sources, India is nearing an agreement to grant foreign COVID-19 vaccine makers such as Pfizer protection against legal liability, as reported in Fidelity.
"Indemnity will be granted," said one of the sources, adding that "if one company gets it then all of them get it."
India has not granted indemnity to any COVID-19 vaccine maker, but the sources said the government was having a change of heart given that the country's vaccination campaign is facing acute shortages.
Pfizer has not sold to any country without obtaining indemnity against legal action over any adverse effects of their product. The company declined to comment on its discussions with the Indian government, but said it sought indemnity wherever it supplied its vaccine.
"We seek the same kind of indemnity and liability protections in all of the countries that have asked to purchase our vaccine, consistent with the local applicable laws to create the appropriate risk protection for all involved," a Pfizer spokeswoman stated.
India invited Pfizer, Moderna and Johnson & Johnson in April to sell their vaccines after infections rocketed, although no deal has been signed, the news source said.
To read more NewsPoints articles, click here.